How to Develop and Implement a National Drug Policy (Second Edition)
(2001; 96 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoContributors
Ver el documentoAbbreviations and acronyms
Ver el documentoPreface
Abrir esta carpeta y ver su contenidoPart I: How to develop and implement a national drug policy
Cerrar esta carpetaPart II: Key components of a national drug policy
Abrir esta carpeta y ver su contenido4. Selection of essential drugs
Abrir esta carpeta y ver su contenido5. Affordability
Abrir esta carpeta y ver su contenido6. Drug financing
Abrir esta carpeta y ver su contenido7. Supply systems
Abrir esta carpeta y ver su contenido8. Drug regulation
Abrir esta carpeta y ver su contenido9. Rational use of drugs
Cerrar esta carpeta10. Research
Ver el documento10.1 Introduction
Ver el documento10.2 Strategies to promote research
Abrir esta carpeta y ver su contenido11. Human resources development
Abrir esta carpeta y ver su contenido12. Monitoring and evaluation
Ver el documentoReferences
Ver el documentoSelected WHO publications and documents of related interest
Ver el documentoBack cover
 

10.1 Introduction

Types of research

There are two categories of research that are of particular importance in the development and implementation of national drug policy. Operational research is aimed at better understanding of factors affecting drug use, and identifying the best methods of selecting, procuring, distributing and using drugs. Its results help to identify and implement practical and cost-effective measures, and should underpin management decisions. Drug research and development includes a broad range of activities, including research into new drugs, drugs for neglected infectious diseases, new dosage forms and manufacturing processes; basic research in chemistry and molecular biology; and clinical and field trials of drugs and vaccines.

Research as a component of a national drug policy

Operational research facilitates the implementation, monitoring and evaluation of different aspects of drug policy. It is an essential tool in assessing the impact of the drug policy on health service systems and delivery, in studying the economics of drug supply, in identifying problems related to prescribing and dispensing, and in understanding the socio-cultural aspects of drug use. It is one of the key ways of identifying which measures work and whether they are being implemented effectively. Operational research is needed at all levels of the health service in both industrialized and developing countries, and should be included in every national drug policy.

On the other hand, the capacity of countries to undertake drug research and development varies enormously. It is important that countries assess their capacity and consider carefully whether they can usefully be involved in drug research and development, and if so, what their priorities should be.

Challenges

Probably the most important challenge is that most health workers and policymakers, and even many staff members of academic institutions, have no time for operational research and are often not really interested in it. Having an open mind to the results of operational research also implies a critical attitude and a willingness to change. The second challenge is that when operational research is finally done, its results are often not fully used to improve strategies and prepare or adapt action plans. For this reason operational research studies should always be developed and carried out in close collaboration with policy-makers. Governments may need to fund such research, in order to ensure that it is undertaken.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013